Joseph Wagner's most recent trade in Notable Labs Inc was a trade of 200,000 Stock Options done . Disclosure was reported to the exchange on May 8, 2024.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Notable Labs Inc | Joseph Wagner | Chief Scientific Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 May 2024 | 200,000 | 200,000 | - | - | Stock Options | |
Clover Health Investments ... | Joseph Wagner | Chief Financial Officer | 09 Aug 2021 | 25,000 | 0 | - | - | Class B Common Stock | ||
Clover Health Investments ... | Joseph Wagner | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 25,000 | 25,000 | - | - | Class B Common Stock | |
Clover Health Investments ... | Joseph Wagner | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 09 Aug 2021 | 25,000 | 492,018 | - | - | Stock Options (right to buy) | |
Clover Health Investments ... | Joseph Wagner | Chief Financial Officer | 09 Aug 2021 | 25,000 | 25,000 | - | - | Class A Common Stock |